You are here

  • Home
  • Archive
  • Volume 13, Issue Suppl 2
  • Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

Article metrics

Article menu
Download PDFPDF
Original Articles
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

 

Online download statistics by month:

Online download statistics by month: March 2019 to December 2024

AbstractFullPdf
Mar 20191800
Apr 20191400
May 20192002
Jun 2019500
Jul 20191100
Aug 20191500
Sep 20193304
Oct 20191401
Nov 20191402
Dec 2019701
Jan 20201200
Feb 20201901
Mar 20202500
Apr 20201400
May 20201200
Jun 2020400
Jul 20202600
Aug 20202000
Sep 20202100
Oct 20203100
Nov 20202001
Dec 20202600
Jan 20211700
Feb 20211000
Mar 20211200
Apr 20211200
May 2021200
Jun 2021100
Jul 2021100
Aug 2021301
Sep 2021200
Oct 2021800
Nov 2021200
Dec 20211600
Jan 20221501
Feb 20222700
Mar 20221901
Apr 20221100
May 20225600
Jun 20225001
Jul 20226101
Aug 20224400
Sep 20225402
Oct 20224900
Nov 20223201
Dec 20222800
Jan 20232000
Feb 20235400
Mar 20231900
Apr 2023900
May 20231100
Jun 2023600
Jul 20231400
Aug 20231600
Sep 20233000
Oct 20231806
Nov 20232900
Dec 20232900
Jan 20241200
Feb 2024900
Mar 20241200
Apr 20241701
May 20242400
Jun 20243300
Jul 20241200
Aug 20242801
Sep 20243501
Oct 20242902
Nov 20243300
Dec 2024900
Total1421031